Evidence map›Paper›PMID 36286044›Full record

ArticleCurrent issues in molecular biology2022

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma.

F A Dain Md Opo, Saleh Alkarim, Ghadeer I Alrefaei, Mohammad Habibur Rahman Molla, Nouf H Alsubhi, Faisal Alzahrani, Foysal Ahammad

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Alleviation of carbendazim toxicity effect bySaudi journal of biological sciences · 2024
    Article
  6. Article
  7. Proposition ofCombinatorial chemistry & high throughput screening · 2024
    Review
  8. Article
  9. Article
  10. Mechanistic insight ofFrontiers in chemistry · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

F A Dain Md OpoDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.
Saleh AlkarimDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.ORCID 0000-0002-2217-1615
Ghadeer I AlrefaeiDepartment of Biology, College of Science, University of Jeddah, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0615-5321
Mohammad Habibur Rahman MollaDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.
Nouf H AlsubhiDepartment of Biological Sciences, College of Science & Arts, King Abdulaziz University (KAU), Rabigh 21911, Saudi Arabia.ORCID 0000-0003-4450-0210
Faisal AlzahraniEmbryonic Stem Cell Research Unit, King Fahd Medical Research Center (KFMRC), King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0441-4000
Foysal AhammadDepartment of Biological Science, Faculty of Sciences, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.ORCID 0000-0001-7313-4729
King Abdulaziz University · SAUniversity of Jeddah · SA

Funding

King Abdulaziz University Grant Number: IFPRC-115-130-2020
6 · The paper itself

Abstract

The mortality of cancer patients with neuroblastoma is increasing due to the limited availability of specific treatment options. Few drug candidates for combating neuroblastoma have been developed, and identifying novel therapeutic candidates against the disease is an urgent issue. It has been found that

Indexed as

Brd4dynamic simulationmolecular dockingMYCNneuroblastomapharmacophore modelside effects

Identifiers

PMID36286044
PMCPMC9600652
OpenAlexW4306149540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.